FIGURE

Fig. 2

ID
ZDB-FIG-220927-41
Publication
Saronni et al., 2022 - Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer
Other Figures
All Figure Page
Back to All Figure Page
Fig. 2

Dose-dependent effect of SU5402, sulfatinib and SPP86 on cell viability of TT (a) and MZ-CRC-1 (b) cell lines, as measured by the MTT assay. Cells were incubated for 6 days with vehicle (control) or with the drug at different concentrations, as described in Material and Methods. Dose response curves were expressed as nonlinear regression (curve fit) of log (concentration drug) versus the percentage of control. Values represent the mean and standard error of the mean of at least three independent experiments in six replicates. **: p < 0.01, ***: p < 0.001, CTR: control, MTT: 3-(4,5-dymethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.

Expression Data

Expression Detail
Antibody Labeling
Phenotype Data

Phenotype Detail
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cancers